Cian Healthcare Ltd.

21.42 +0.79 ▲3.8%

28 March 2024, 04:01:00 PM
Volume: 26,000

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.cian.co
Market Cap 51.67 Cr.
Enterprise Value(EV) 91.95 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.81 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 25.46 Trailing Twelve Months Ending 2023-03
Industry PE 41.54 Trailing Twelve Months Ending 2023-03
Book Value / Share 18.98 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.09 Calculated using Price: 20.67
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 2.50 Cr. 24,995,764 Shares
FaceValue 10
About Cian Healthcare Ltd.
The Company develops, manufactures and commercializes pharmaceutical products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals, along with 10 sales division focused on developing and growing its engagements in specialist and super specialist division. The company works under different business models like Brand Business, Export, Third Party Manufacturing and Government Supplies. The Company manufactures innovative products comprising of Tablets, Capsules, Liquid Orals, Ointments, Creams, Lotions, Gels and Sachet. The Company has special licence for manufacturing veterinary products for client like SAVAvet and Venky's.

Cian Healthcare Ltd. Delivery

Delivered Qty
Traded Qty

Cian Healthcare Ltd. Performance

1 Day
+3.83%
1 Week
+1.37%
1 Month
-7.91%
3 Month
+25.26%
6 Month
-0.65%
1 Year
-26.14%
2 Year
+1.28%
5 Year
10 Year

Cian Healthcare Ltd. Fundamental Ratios

4 years 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -7.53 0.1 -10.51 4.06
Return on Capital Employed (%) 3 6.99 0.46 7.41
Return on Assets (%) -2.42 0.03 -3.42 1.24

Cian Healthcare Ltd. Balance Sheet

Particulars 5 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 58 58 55 57 56
Non Curr. Liab. 50 41 41 38 37
Curr. Liab. 48 58 69 65 71
Minority Int.
Equity & Liab. 157 157 166 160 163
Non Curr. Assets 94 88 84 76 84
Curr. Assets 54 63 79 74 79
Misc. Exp. not W/O 8 5 3 10
Total Assets 157 157 166 160 163

Cian Healthcare Ltd. Profit and Loss

Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 57 74 78 69
Other Income 1 0 1 1
Total Income 58 74 78 69
Total Expenditure -50 -62 -74 -56
PBIDT 8 12 5 14
Interest -7 -8 -7 -6
Depreciation -4 -3 -4 -5
Taxation 0 -1 0 0
Exceptional Items 0 0 0 0
PAT -4 0 -6 2
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -4 0 -6 2
Adjusted EPS -2 0 -2 1

Cian Healthcare Ltd. Cash Flow

Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -7 6 9 5
Cash Fr. Inv. -27 3 1 3
Cash Fr. Finan. 36 -10 -11 -7
Net Change 1 -1 -1 0
Cash & Cash Eqvt 3 2 1 1

Cian Healthcare Ltd. Shareholding Pattern

9 Qtrs 2020-09 (%) 2021-03 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-09 (%)
Promoter 70.89 70.89 70.89 66.26 66.26 66.26 66.26 51.85 49.62
Public 29.11 29.11 29.11 33.74 33.74 33.74 33.74 48.15 50.38
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 10.14 10.14 20.14 14.11 34.11 34.11 34.11 18.02 18.83
No. of Shareholders (in Lacs)

Cian Healthcare Ltd. Announcements

Tue, 19 Mar 2024
Receipt Of Adjudication Order Of Penalties Under Section 454(3) Read With 117 Of The Companies Act 2013.
Receipt of Adjudication order of Penalties under Section 454(3) read with 117 of Companies Act 2013.
Thu, 29 Feb 2024
Intimation Of Amendment Of Policies
Intimation of Amendment of Policies
Tue, 20 Feb 2024
Intimation Of Winning Of Tender Of Pharmaceutical And Medical Device Bureau Of India (PMBI)
Intimation of winning of Tender of PMBI for supply of various Drugs and Medicines

Cian Healthcare Ltd. Technical Scans

Thu, 28 Mar 2024
Opening at High Opening at High
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 3 Months High Increase in 3 Months
Closing Near 100 SMA Closing Near 100 SMA

Cian Healthcare Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 388,812.23 1,620.50 +0.8%
Cipla Ltd. 120,673.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. 102,679.14 6,171.85 +2.0%
Zydus Lifesciences Ltd. 101,151.67 1,007.35 +0.8%
Mankind Pharma Ltd. 92,029.19 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. 91,330.58 6,347.35 +1.9%
Divi's Laboratories Ltd. 91,234.91 3,452.55 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 43.66 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 32.54 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.64 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 34.01 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 53.29 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.71 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 65.97 3,452.55 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.23 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 4.66 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.82 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.37 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 10.36 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.52 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 7.00 3,452.55 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,452.55 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,452.55 +2.6%

Cian Healthcare Ltd. FAQ's

What is Cian Healthcare share price?

Can I buy Cian Healthcare shares now?

What is the Market Cap of Cian Healthcare?

What are the key metrics to analyse Cian Healthcare?

What is the 52 Week High and Low of Cian Healthcare?

What is the trend of Cian Healthcare share price?